Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema
Clinical trial NCT02732951 · COMPLETED
Trial details
- NCT number
- NCT02732951
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-14
- Primary completion
- 2017-10-23
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.